Cargando…
Preclinical verification of the efficacy by targeting peptide-linked liposomal nanoparticles for hepatocellular carcinoma therapy
The purpose of this study was to investigate the efficacy of targeting peptides chemotherapy to overcome adverse event in the conventional chemotherapy for human hepatocellular carcinoma. Previously we reported several cancer-targeting peptides that bind specifically to cancer cells and their vascul...
Autores principales: | Wu, Cheng-Der, Lee, Jen-Chieh, Wu, Hang-Chung, Lee, Chung-Wei, Lin, Chih-Feng, Hsu, Ming-Chen, Lin, Chin-Tarng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937529/ https://www.ncbi.nlm.nih.gov/pubmed/31908670 http://dx.doi.org/10.1177/1849543519880762 |
Ejemplares similares
-
A Novel Peptide Enhances Therapeutic Efficacy of Liposomal Anti-Cancer Drugs in Mice Models of Human Lung Cancer
por: Chang, De-Kuan, et al.
Publicado: (2009) -
Liposomal paclitaxel induces fewer hematopoietic and cardiovascular complications than bioequivalent doses of Taxol
por: Huang, Shih-Ting, et al.
Publicado: (2018) -
Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent
por: Lv, Huiqing, et al.
Publicado: (2016) -
Liposomal Irinotecan for Treatment of Colorectal Cancer in a Preclinical Model
por: Huang, Jiao-Ren, et al.
Publicado: (2019) -
iRGD Peptide-Mediated Liposomal Nanoparticles with Photoacoustic/Ultrasound Dual-Modality Imaging for Precision Theranostics Against Hepatocellular Carcinoma
por: Li, Huipu, et al.
Publicado: (2021)